Menu

RVL Pharmaceuticals plc RVLP

Full chart Compare
Set alert

Price alert · RVLP

All alert types
0.03 +0.03

Day range unavailable

52-week range unavailable

Revenue & Expenses

Other Income → Expenses: $7.53MIncome Tax Benefit → Expenses: $20.00KExpenses → Selling, General & Admin: $81.98MExpenses → Research & Development: $3.97MExpenses → Other Operating Expenses: $13.31MExpenses → Interest Expense: $253.00KGross Profit → Expenses: $40.27MRevenue → Gross Profit: $40.27MRevenue → Cost of Revenue: $9.46MNet Loss → Expenses: $51.69MOther Income$7.53MIncome Tax Benefit$20.00KGross Profit$40.27MNet Loss$51.69MCost of Revenue$9.46MExpenses$99.51MSelling, General & Admin$81.98MResearch & Development$3.97MOther Operating Expenses$13.31MInterest Expense$253.00KRevenue$49.72M

Latest period ending Dec 31, 2022 · select a line to chart its full history

Annual income statement

RVLP annual income statement
Fiscal yearFY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019FY 2018 Dec 31, 2018
49.72M17.50M27.76M240.03M263.70M
49.72M17.50M27.76M240.03M263.70M
9.46M3.62M3.29M111.63M140.08M
40.27M13.88M24.47M128.40M123.62M
99.25M96.64M115.12M409.10M222.16M
3.97M6.93M13.39M32.32M43.69M
81.98M87.46M72.82M93.03M74.24M
-58.99M-82.75M-90.65M-280.69M-98.54M
253.00K4.02M4.09M18.21M20.79M
-20.00K315.00K-5.78M-27.12M-8.98M
-51.69M-64.92M-79.59M-270.90M-109.68M
-51.69M-64.92M-79.59M-270.90M-109.68M
-51.69M-64.92M-79.59M-270.90M-109.68M
-51.69M-64.92M-79.59M-270.90M-109.68M
-0.58-0.96-1.31-5.17-2.42
-0.58-0.96-1.31-5.17-2.42
-0.58-0.96-1.31-5.17-2.42
-51.46M-60.59M-81.28M-279.81M-97.87M
-51.46M-60.59M-81.28M-279.81M-97.87M
89.80M67.35M60.65M52.37M45.28M
89.80M67.35M60.65M52.37M45.28M